<DOC>
	<DOCNO>NCT00951210</DOCNO>
	<brief_summary>The purpose study determine safety PLX-PAD , Intra-muscular injection treatment CLI patient .</brief_summary>
	<brief_title>Safety Intramuscular Injections ( IM ) Allogeneic PLX-PAD Cells Treatment Critical Limb Ischemia ( CLI )</brief_title>
	<detailed_description />
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Vascular Diseases</mesh_term>
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<mesh_term>Peripheral Vascular Diseases</mesh_term>
	<criteria>1 . Diagnosis critical limb ischemia define persistent , recur ischemic rest pain least two ( 2 ) week , and/or ulceration gangrene foot toe , ABI &lt; 0.6 or/and TBI &lt; 0.4 2 . Rutherford category 45 3 . Non candidate revascularization endovascular intervention base unfavorable vascular anatomy significant comorbid medical condition confirm vascular study ( e.g. , angiogram , MRA ) obtain within 3 month prior screen visit sign approval vascular surgeon . The decision classify subject noncandidate make investigator confirmed independent third party vascular surgeon participate study . 4 . In opinion investigator , major amputation anticipate period three ( 3 ) month . 5 . Those diabetic subject optimal diabetes medication , HbA1c &lt; 8 % 1 . Uncontrolled hypertension ( define diastolic blood pressure &gt; 110 mmHg systolic blood pressure &gt; 180 mmHg screening ) . 2 . Wounds severity great Grade 2 Wagner Scale 3 . Lifethreatening ventricular arrhythmia except ICD implant unstable angina characterize increasingly frequent episode modest exertion rest , worsen severity , prolong . 4 . ST segment elevation myocardial infarction and/or TIA/CVA within six ( 6 ) month prior enrollment.Patients severe congestive heart failure ( i.e . NYHA Stage IV ) 5 . In opinion investigator , patient unsuitable cellular therapy .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>81 Years</maximum_age>
	<verification_date>November 2011</verification_date>
	<keyword>Peripheral Artery Disease</keyword>
	<keyword>Peripheral Vascular Disease</keyword>
	<keyword>Critical limb ischemia</keyword>
	<keyword>PAD</keyword>
	<keyword>CLI</keyword>
</DOC>